Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3.7Revenue $M94.4Net Margin (%)6,414Z-Score-130.5
Enterprise Value $M0.4EPS $-2.6Operating Margin %-13,014.3F-Score6
P/E(ttm))1.6Cash Flow Per Share $0Pre-tax Margin (%)6,414Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %-43.1Quick Ratio20.8Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %-26.4Current Ratio20.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)24.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)1,563Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M37.5ROI % (ttm)-247.0Gross Margin Increase y-yY

Gurus Latest Trades with AFFY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AFFYGeorge Soros 2012-03-31 Sold Out -0.06%$6.53 - $14.31
($9.16)
$ 0.13-99%Sold Out0
AFFYGeorge Soros 2011-12-31 Add0.05%$4.24 - $7.8
($5.4)
$ 0.13-98%Add 800.9%200,000
AFFYGeorge Soros 2011-09-30 Reduce-0.01%$4.04 - $7.78
($5.48)
$ 0.13-98%Reduce -83.4%22,200
AFFYGeorge Soros 2011-06-30 Buy 0.01%$5.85 - $7.16
($6.56)
$ 0.13-98%New holding, 133717 sh.133,717
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AFFY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AFFY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WALKER JOHN PETERDirector 2013-08-28Sell16,540$1.92-95.31view
Knapp Jeffrey HChief Commercial Officer 2012-03-27Sell0$0-95.31view
APAX PARTNERS EUROPE MANAGERS 10% Owner 2006-12-14Sell0$0-95.31view
Mahdavi AliVP, Finance and Administration 2006-12-14Sell0$0-95.31view
APAX MANAGERS INC10% Owner 2006-12-14Sell0$0-95.31view
CREDIT SUISSE/10% Owner 2006-12-14Sell0$0-95.31view
MPM BIOVENTURES II QP LP10% Owner 2006-12-14Sell0$0-95.31view
MPM BioVentures Strategic Fund10% Owner 2006-12-14Sell0$0-95.31view
GALAKATOS NICHOLASDirector, 10% Owner 2006-12-14Sell0$0-95.31view
Morris ArlenePresident and CEO 2006-12-14Sell0$0-95.31view

Press Releases about AFFY :

    Quarterly/Annual Reports about AFFY:

    News about AFFY:

    Articles On GuruFocus.com
    Dead Biotech Plays Surge To Life May 07 2013 
    comment on AFFY Mar 15 2013 
    comment on AFFY Mar 02 2013 
    Weekly CFO Sells Highlight: PII, ASNA, FIO, VVUS, AFFY Jul 23 2012 
    AFFYMAX, INC. (AFFY) CEO Arlene Morris sells 52,896 Shares May 19 2010 
    AFFYMAX, INC. (AFFY) CEO Arlene Morris sells 180,410 Shares May 13 2010 
    AFFYMAX, INC. (AFFY) EVP, Corp. Development and CFO Paul B Cleveland sells 55,935 Shares Feb 26 2010 
    AFFYMAX, INC. (AFFY) President and CEO Arlene Morris sells 101,100 Shares Sep 30 2009 
    AFFYMAX, INC. (AFFY) President and CEO Arlene Morris sells 6,555 Shares Sep 02 2009 
    AFFYMAX, INC. Reports Operating Results (10-Q) Aug 05 2009 

    More From Other Websites
    Affymax, Inc. Announces a Special Cash Distribution And The Appointment Of a New Director And Chief... Nov 26 2014
    Affymax Adopts Tax Benefit Preservation Plan to Protect Net Operating Loss Carryforwards Nov 26 2014
    Affymax, Inc. Announces a Special Cash Distribution and the Appointment of a New Director and Chief... Nov 26 2014
    Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc.... Nov 17 2014
    AFFYMAX INC Files SEC form 8-K, Other Events Sep 24 2014
    Xstelos Announces Intention To Vote Against Affymax's Plan Of Liquidation At September 23, 2014... Sep 19 2014
    Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc.... Sep 12 2014
    AFFYMAX INC Financials Aug 09 2014
    AFFYMAX INC Files SEC form 10-Q, Quarterly Report Jul 31 2014
    Affymax Reports Second Quarter 2014 Financial Results Jul 31 2014
    AFFYMAX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 18 2014
    AFFYMAX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 24 2014
    Affymax board announces decision to dissolve company Jun 24 2014
    Affymax Board Announces Decision to Dissolve the Company Jun 24 2014
    AFFYMAX INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements... Jun 13 2014
    Affymax and Takeda Announce Termination of Omontys® (peginesatide) Product Collaboration and... Jun 13 2014
    Affymax and Takeda Announce Termination of Omontys® (peginesatide) Product Collaboration and... Jun 13 2014
    AFFYMAX INC Files SEC form 8-K, Other Events May 14 2014
    AFFYMAX INC Files SEC form 10-Q, Quarterly Report May 06 2014
    AFFYMAX INC Files SEC form 10-K, Annual Report Mar 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK